Össur hf: Interim report Q3 2023
Announcement no. 16/2023 Interim report Q3 2023 24 October 2023 Sveinn Sölvason, President and CEO, Comments: “Sales amounted to 193 million, with 7% organic growth, and the EBITDA margin was 19% in Q3 2023. Organic growth was 9% in the first nine months, driven by a strong contribution in all our business segments and regions. We continue to be on track to deliver on our ambition to grow 7-10% in average local currency growth in 2023-2027, in line with our recently launched Growth’27 strategy. We see strong volume growth within Prosthetics and Patient Care, and I am pleased to